Neurosyntek Overview

  • Founded
  • 2007
  • Status
  • Private
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $2M
Latest Deal Amount
  • Investors
  • 1

Neurosyntek General Information


Provider of a cell sorting platform intended to accelerate cell therapy discovery and treatments. The company's platform provides CellOptimiser which is a fluorescence or morphology directed cell culture-sorting system that gives an unprecedented control over the cellular behavior though an AI technology, enabling patients to get effective cell therapy treatments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Discovery Tools (Healthcare)
Therapeutic Devices
Primary Office
  • 932 Lundy Lane
  • Los Altos, CA 94024
  • United States
+1 (650) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurosyntek Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC $2M 000 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2013 Completed Generating Revenue

Neurosyntek Executive Team (4)

Name Title Board Seat Contact Info
Victor Boksha Ph.D Co-Founder & Executive Chairman
Paul Molchanov Co-Founder & Principal Architect
Richard Foster Co-Founder & Strategic Advisor
James Hogan Co-Founder & Strategic Advisor

Neurosyntek Investors (1)

To view Neurosyntek‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
MedTech Innovator Accelerator/Incubator 000 0000 000000 0

Ready to get started?

Request a free trial